Showing results (1281-1290 of 1,668) with videos related to

Sort By:
Pageof 167
Annals of the Rheumatic Diseases|September 4, 2004
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritisE N van Roon, T L T A Jansen, M A F J van de Laar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2009
Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imagingMarco H M Janssen, Michel C Ollers, Robert G Riedl, et al.
American Journal of Medical Genetics. Part A|September 3, 2009
Identical cryptic partial monosomy 20pter and trisomy 20qter in three adult siblings due to a large maternal pericentric inversion: detection by MLPA and breakpoint mapping by SNP array analysisServi J C Stevens, Eric E J G L Smeets, Eveline Blom, et al.
Tissue Engineering. Part A|September 3, 2020
Inconsistency in Graft Outcome of Bilayered Bioresorbable Supramolecular Arterial Scaffolds in RatsRenee Duijvelshoff, Andrea di Luca, Eline E van Haaften, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
PD1 blockade enhances K+ channel activity, Ca2+ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancerHannah S Newton, Vaibhavkumar S Gawali, Ameet A Chimote, et al.
JIMD Reports|January 17, 2017
Domains of Daily Physical Activity in Children with Mitochondrial Disease: A 3D Accelerometry ApproachSaskia Koene, Ilse Dirks, Esmee van Mierlo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patientsMarco H M Janssen, Hugo J W L Aerts, Michel C Ollers, et al.
Cancer Research|July 27, 2011
Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cellsStefan Nierkens, Martijn H den Brok, Zacharias Garcia, et al.
European Journal of Haematology|April 11, 2022
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the NetherlandsSimone Claudiani, Jeroen J W M Janssen, Jenny Byrne, et al.
Physics and Imaging in Radiation Oncology|August 6, 2021
The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patientsM E Nowee, V W J van Pelt, I Walraven, et al.
Pageof 167